Table 2.
All participantsn = 100 | COVID+ ICU+n = 49 | COVID+ICU-n = 24 | COVID - ICU+(ICU Controls)n = 16 | p value | ||
---|---|---|---|---|---|---|
Outcome | ||||||
ICU length of stay (days) | 14.0 [10.0; 26.0] | 15.0 [10.0; 26.0] | NR | 11.0 [6.8; 18.5] | 0.115 | |
Hospital length of stay (days) | 20.0 [9.0; 37.0] | 27.0 [17.0; 47.0] | 6.5 [2.0; 10.0] | 26.5 [15.0; 49.8] | <0.001 | |
ICU-mortality (%) | 16 (24.6) | 10 (20.4) | NR | 6 (37.5) | 0.297 | |
In-hospital mortality (%) | 25 (28.1) | 12 (24.5) | 7 (29.2) | 6 (37.5) | 0.562 | |
Thromboembolic event within hospital: n (%) | 13 (14.6) | 9 (18.4) | 0 (0.0) | 4 (25.0) | 0.028 | |
Care-related infection: number of patients (%) | 32 (36.0) | 24 (49) | 0 (0) | 8 (50) | <0.001 | |
Causes of death (n, %) | ||||||
- Refractory hypoxemia/lung fibrosis | 8 (9.0) | 1 (2) | 7 (29.2) | 0 | <0.001 | |
- Multiple Organ Failure | 15 (16.9) | 9 (18.4) | 0 (0) | 6 (37.5) | 0.003 | |
- Withdrawing & Withholding decisions | 22 (24.7) | 9 (18.4) | 7 (29.2) | 6 (37.5) | 0.234 |
Data are either median [IQ1; IQ3]) or number (percentage, %).
NR, not relevant.
ICU, intensive care unit.